Population screening for cancer
91 results
1 - 91
Consequences of screening for lung cancer (NELSON)- Screening mammography overdiagnoses women with breast cancer
- HPV-based screening can replace cytology-based screening for cervical cancer
- HPV DNA screening detects CIN3 and cancer earlier
- Colon cancer screening may be beneficial for Lynch syndrome
- Elders want a say in when to stop cancer screenings
- Ovarian cancer screening does not improve outcomes (UKCTOCS)
- Lung cancer screening is cost effective, but only if done correctly
- Colorectal cancer screening modalities: variable uptake, variable yield (SAVE)
- The full truth about prostate cancer screening is suppressed again (ERSPC)
- Systematic review: lung cancer screening with CT decreases mortality but with significant harms
- Navigation program slightly decreases time to resolution of abnormal cancer screening results
- New screening test for nasopharyngeal cancer accurate but not proven to improve patient outcomes
- Mailing FIT or gFOBT directly to patients increases uptake of colorectal cancer screening
- Have the USPSTF recommendations against screening caused more aggressive prostate cancer?
- Screening CA-125 and transvaginal ultrasound does not reduce ovarian cancer mortality
- Annual screening chest x-ray does not reduce lung cancer mortality
- Prostate cancer screening: no mortality benefit after 15 years of follow-up (PLCO)
- USPSTF 2017 recommends against screening for thyroid cancer in asymptomatic adults (D recommendation)
- FIT more acceptable with better detection rate than gFOBT for colorectal cancer screening
- USPSTF 2018 recommends against screening for ovarian cancer in asymptomatic women (D recommendation)
- USPSTF 2019 recommends against screening for pancreatic cancer in asymptomatic adults (D recommendation)
- Screening for ovarian cancer with CA-125/ultrasound algorithm does not reduce mortality (UKCTOCS)
- Prostate cancer screening: no mortality benefit after 13 years of follow-up (PLCO)
- Lung cancer screening with low-dose CT does not affect smoking cessation rates
- Volume-based low-dose CT screening reduces lung cancer–specific mortality (NELSON)
- Limited benefit for routine cervical cancer screening with co-testing versus HPV testing alone
- Even before the new guidelines, a majority of women stated a preference for breast cancer screening in their 40s
- HPV-based screening more effective to prevent invasive cervical cancer than cytology alone
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- High false positive rate in repeated, multimodal screening for cancers (PLCO)
- USPSTF 2018 recommends counseling 55 to 69-year-old men on benefits and harms of prostate cancer screening (C recommendation)
- After community lung cancer screening, rates of follow-up imaging are lower but the rates of some procedures are higher
- USPSTF 2021 recommends annual lung cancer screening based on shared decision-making in high-risk adults (B recommendation)
- Colon cancer screening with fecal immunochemical tests: False-positive rates vary
- Fecal DNA testing = Hemoccult Sensa for colon cancer screening
- Pedigree identifies hereditary breast cancer syndromes
- Results of fecal immunochemical tests for colorectal cancer screening not affected by NSAIDs, aspirin, or anticoagulants
- Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age
- Digital mammography: more cancers detected, more recalls, more overdiagnosis than film-based mammography
- Signs and symptoms can indicate an increase in the likelihood of ovarian cancer
- Women with normal Pap smears in their 50s unlikely to develop cervical cancer as they age
- Better estimate of prostate cancer risk based on the number of close relatives with prostate cancer and their age at diagnosis
- USPSTF 2016: updated recommendations for colorectal cancer screening
- Cell-free DNA blood test 83% sensitive for colorectal cancer, 13% sensitive for advanced adenoma; mortality data lacking (ECLIPSE)
- Lung cancer screening requires additional imaging in 40% of patients in real world
- Two thirds of reduction in breast cancer mortality due to therapy advances
- Observational study finds lower colorectal CA-specific mortality with colonoscopy
- Aspirin = screening to prevent colorectal cancer mortality
- Low risk of residual CIN after treatment if HPV negative
- Screening for breast cancer: False-positive rates 60% over 10 years
- Uncertain risks and benefits of CT screening for lung cancer
- Markov model: colonoscopy is most effective strategy in improving outcomes
- Subsequent colon cancer is rare in older patients with polyps
- Colorectal neoplasia yield similar for FIT every 1, 2 or 3 years
- Observation = radical prostatectomy for most pts with localized prostate cancer (PIVOT)
- Modelling study shows less-intense screening is okay for men with low baseline PSA levels
- Combined ultrasound + mammogram for high-risk women increases cancer yield
- Negative colonoscopy result predicts no colon cancer for more than 10 years
- Invitation to a single colonoscopy has only modest impact on colorectal cancer incidence (NordICC)
- Rural Black women who are given the option of home HPV sampling are more likely to get screened
- Postcoital bleeding of limited use in determining cervical cancer risk
- FIT has similar yield as colonoscopy for colorectal cancer and advanced adenoma over 10 years
- High adenoma detection rate during colonoscopy associated with lower incidence of colorectal cancer
- Colon CA unlikely if unexplained anemia but ferritin >100 ng/mL
- British guidelines for chronic diarrhea in adults
- Second-generation fecal DNA plus FIT test is more sensitive and specific, but no mortality data (BLUE-C)
- Incidence of complications after conization of the uterine cervix
- Virtual colonoscopy avoids the need for bowel prep
- Value of surveillance in patients with low-risk polyps is uncertain
- Clinical, functional, and demographic factors predict 10-year mortality in adults older than 50